Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

US Patent 11485738 · Granted Nov 1, 2022

Estimated economic value: $69,121,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of palbociclib and adagrasib for lung cancer2025
Kinase inhibitors2025
Rho kinase inhibitors and compositions and methods of use thereof2025
Naphthyridine derivatives as PRC2 inhibitors2025
Naphthyridine derivatives as PRC2 inhibitors2025
Naphthyridine derivatives as PRC2 inhibitors2025
Tetrahydropyridopyrimidine pan-KRas inhibitors2025
Azaquinazoline pan-KRas inhibitors2025
Combination therapies2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025